Showing results (211-220 of 298) with videos related to
Sort By:
Pageof 30
European Journal of Heart Failure|March 24, 2021
Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study)Pankaj Gupta, Adriaan A Voors, Prashanth Patel, et al.European Journal of Heart Failure|March 11, 2015
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registryGerasimos Filippatos, Sadiya Sana Khan, Andrew P Ambrosy, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.Plos One|March 20, 2012
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failureArne Yndestad, Alexandra Vanessa Finsen, Thor Ueland, et al.Circulation. Heart Failure|November 17, 2017
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic CardiomyopathyLi Shen, Felix Ramires, Felipe Martinez, et al.Pageof 30